(Q43601431)

English

A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Nordmann A

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Heilmbauer I

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Walker T

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Martina B

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Battegay E

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

543-550

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

A case-management system for coronary risk factor modification after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients > or = 65 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Compliance and efficacy of cardiac rehabilitation and risk factor modification in the medically indigent

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Report of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

The influence of diet on the appearance of new lesions in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Telephone care as a substitute for routine clinic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Dyslipidemia treatment guidelines and management systems in Kaiser Permanente

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Improving care with nurse case managers: practical aspects of designing lipid clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900682-9

7 January 2021

Identifiers

10.1016/S0002-9343(01)00682-9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43601431&oldid=2101824385"